Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
2018 · New England Journal of Medicine · 1,264 citations
https://doi.org/10.1056/nejmoa1809798
A
Aruna D. Pradhan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
144
Papers
17.3K
Citations
51
h-index
81
i10-index
Aruna D. Pradhan is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Diabetes, Cardiovascular Risks, and Lipoproteins & Adipokines, Inflammation, and Metabolic Diseases & Lipoproteins and Cardiovascular Health. The author has an h-index of 51, co-authored 123 publications.
ORCID: 0000-0003-4321-5960Papers by this author
worksTriglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
2022 · New England Journal of Medicine · 638 citations
https://doi.org/10.1056/nejmoa2210645
Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels
2016 · Nature Communications · 186 citations
https://doi.org/10.1038/ncomms10494
Interrelationships Between Inflammation, C‐Reactive Protein, and Insulin Resistance
2006 · Journal of the CardioMetabolic Syndrome · 116 citations
https://doi.org/10.1111/j.1559-4564.2006.05538.x
Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial
2025 · Nature Communications · 7 citations
https://doi.org/10.1038/s41467-025-58721-6
Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?
2019 · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 6 citations
https://doi.org/10.1016/j.dsx.2019.05.034
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat